Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: J Neurochem. 2014 Jul 10;131(1):21–32. doi: 10.1111/jnc.12780

Fig. 2.

Fig. 2

Effects of cAMP and PKC activation as well as VIP treatment on serpinb1a mRNA expression in PC12 cells. Cells were cultured 6 h in the presence of PACAP (10−7 M), the cAMP activator forskolin (25 µM), the cAMP analog dbcAMP (10−3 M), the PKC activator PMA (10−7 M), a combination of PMA plus forskolin, or VIP (10−7 M). Quantitative PCR results were corrected using the GAPDH signal as internal control and expressed as the mean fold induction (± S.E.M.) of serpinb1a mRNA level compared to the control without activator. * p<0.05 and ** p<0.01 versus control.